SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-015875
Filing Date
2023-05-25
Accepted
2023-05-25 17:00:13
Documents
16
Period of Report
2023-05-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20230523_8k.htm   iXBRL 8-K 37301
2 EXHIBIT 99.1 ex_525160.htm EX-99.1 24099
3 EXHIBIT 99.2 ex_526603.htm EX-99.2 20502
8 pic1.jpg GRAPHIC 3235
  Complete submission text file 0001437749-23-015875.txt   235283

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arav-20230525.xsd EX-101.SCH 3601
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20230525_def.xml EX-101.DEF 11919
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20230525_lab.xml EX-101.LAB 15966
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20230525_pre.xml EX-101.PRE 12130
10 EXTRACTED XBRL INSTANCE DOCUMENT arav20230523_8k_htm.xml XML 2655
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 23961788
SIC: 2834 Pharmaceutical Preparations